805 related articles for article (PubMed ID: 34156552)
1. [
Skawran S; Gennari AG; Dittli M; Treyer V; Muehlematter UJ; Maurer A; Burger IA; Mader C; Messerli O; Grünig H; Gebhard C; Huellner MW; Curioni-Fontecedro A; Berger C; Messerli M
Eur Radiol; 2022 Jan; 32(1):508-516. PubMed ID: 34156552
[TBL] [Abstract][Full Text] [Related]
2. Frequency and Characteristics of Nodal and Deltoid FDG and
Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
[No Abstract] [Full Text] [Related]
3. The systemic impact of different COVID-19 vaccines in 2-[18F] FDG-PET/CT.
Nazerani-Zemann T; Pernthaler B; Schwantzer G; Gstettner C
Sci Rep; 2023 Dec; 13(1):21838. PubMed ID: 38071353
[TBL] [Abstract][Full Text] [Related]
4. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
5. Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era.
Giordano A; Gallicchio R; Milella M; Storto R; Nardelli A; Pellegrino T; Nappi A; Di Cosola M; Storto G
Curr Pharm Des; 2024; 30(10):798-806. PubMed ID: 38454762
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of metabolic changes in FDG PET/CT imaging after mRNA-based COVID-19 vaccination.
İşgören S; Köroğlu G; Görür GD; Demir H
Turk J Med Sci; 2022 Dec; 52(6):1745-1753. PubMed ID: 36945983
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-Related Lymph Nodes: The Emerging Pitfalls of 18F-Fluorocholine and 68Ga-PSMA-11 PET/CT in the Era of COVID-19 Vaccination.
Ah-Thiane L; Ferrer L; Maucherat B; Fleury V; Le Thiec M; Rusu D; Rousseau C
Clin Nucl Med; 2022 Jul; 47(7):575-582. PubMed ID: 35675134
[TBL] [Abstract][Full Text] [Related]
8. [
Kubota K; Saginoya T; Ishiwata K; Nakasato T; Munechika H
Ann Nucl Med; 2022 Apr; 36(4):340-350. PubMed ID: 35098436
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccine related hypermetabolic lymph nodes on PET/CT: Implications of inflammatory findings in cancer imaging.
Calabria F; Bagnato A; Guadagnino G; Toteda M; Lanzillotta A; Cardei S; Tavolaro R; Leporace M
Oncol Res; 2023; 31(2):117-124. PubMed ID: 37304242
[TBL] [Abstract][Full Text] [Related]
10. Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination on
Notohamiprodjo S; Eiber M; Lohrmann C; Weber WA
J Nucl Med; 2022 Nov; 63(11):1673-1676. PubMed ID: 35241484
[TBL] [Abstract][Full Text] [Related]
11. The Effects of CoronaVac (Sinovac) and BNT162b2 (BioNTech/Pfizer) Vaccination on Oncologic
Şan H; Alagöz E
Mol Imaging Radionucl Ther; 2022 Oct; 31(3):179-190. PubMed ID: 36268854
[TBL] [Abstract][Full Text] [Related]
12. Axillary Lymph Node Uptake on
Otomi Y; Shinya T; Kasai H; Okada N; Matsushita T; Higashi K; Matsuzaki S; Hiroshima Y; Kubo M; Otsuka H; Harada M
Mol Imaging Radionucl Ther; 2023 Feb; 32(1):13-19. PubMed ID: 36817634
[TBL] [Abstract][Full Text] [Related]
13. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [
Cohen D; Krauthammer SH; Wolf I; Even-Sapir E
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1854-1863. PubMed ID: 33774684
[TBL] [Abstract][Full Text] [Related]
14.
Peacock JG; Banks EA; McWhorter N
J Nucl Med Technol; 2022 Mar; 50(1):73-74. PubMed ID: 34872921
[TBL] [Abstract][Full Text] [Related]
15. Lessons Learned from Post-COVID-19 Vaccination PET/CT Studies.
Orevi M; Chicheportiche A; Ben Haim S
J Nucl Med; 2022 Mar; 63(3):453-460. PubMed ID: 34301777
[TBL] [Abstract][Full Text] [Related]
16. Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on
Chiang MT; Wang JT; Lin WY; Yen RF; Huang JY; Lu CC
Eur J Med Res; 2023 Nov; 28(1):513. PubMed ID: 37964395
[TBL] [Abstract][Full Text] [Related]
17. Comparison between viral vector and mRNA based COVID-19 vaccination in prevalence and severity of regional immune reactions, and
Ayati N; Evans S; Zakavi SR; Gruenewald SM
Asia Ocean J Nucl Med Biol; 2023; 11(1):4-12. PubMed ID: 36619184
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management.
McIntosh LJ; Bankier AA; Vijayaraghavan GR; Licho R; Rosen MP
AJR Am J Roentgenol; 2021 Oct; 217(4):975-983. PubMed ID: 33646823
[TBL] [Abstract][Full Text] [Related]
19. Morphological and Metabolic Criteria of COVID-19 Vaccine Associated Axillary Nodes on 18-Fluorodeouxyglucose PET/CT Imaging in Breast Cancer Patients.
Fatima N; Zaman U; Zaman A; Zaman S; Tahseen R; Zaman MU
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4053-4057. PubMed ID: 38156837
[TBL] [Abstract][Full Text] [Related]
20. The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on
El-Sayed MS; Wechie GN; Low CS; Adesanya O; Rao N; Leung VJ
Clin Med (Lond); 2021 Nov; 21(6):e633-e638. PubMed ID: 34862224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
